Full Transcript The 2002 Study That Changed Everything 0:01 In 2002, a large 0:01 In 2002, a large study was 0:02 study was 0:02 study was stopped early, 0:03 stopped early, 0:03 stopped early, and the headline read 0:05 and the headline read 0:05 and the headline read that 0:05 that 0:05 that hormone replacement therapy ( 0:07 hormone replacement therapy ( HRT) causes 0:08 HRT) causes 0:08 HRT) causes breast cancer. This 0:10 breast cancer. This 0:10 breast cancer. This headline shaped how an 0:11 headline shaped how an 0:11 headline shaped how an entire generation of 0:12 entire generation of 0:12 entire generation of women and their 0:13 women and their 0:13 women and their doctors think about 0:14 doctors think about 0:14 doctors think about hormone therapy. 0:15 hormone therapy. 0:16 hormone therapy. 20 years later, the evidence 0:18 20 years later, the evidence 0:18 20 years later, the evidence has become more subtle. 0:19 has become more subtle. 0:19 has become more subtle. The FDA just changed its 0:21 The FDA just changed its 0:21 The FDA just changed its guidelines in 0:22 guidelines in 0:22 guidelines in 2025, and millions of 0:23 2025, and millions of 0:23 2025, and millions of women are still making 0:25 women are still making 0:25 women are still making decisions based on 0:26 decisions based on 0:26 decisions based on headlines from a time before 0:28 headlines from a time before 0:31 smartphones. Today 0:31 smartphones. Today I'm going to tell you what the 0:32 I'm going to tell you what the 0:35 research actually shows. 0:35 research actually shows. Welcome to my channel. 0:36 Welcome to my channel. 0:37 Welcome to my channel. I am Dr. Elizabeth 0:38 I am Dr. Elizabeth 0:38 I am Dr. Elizabeth Tatakin, a 0:38 Tatakin, a 0:38 Tatakin, a licensed naturopathic doctor 0:39 licensed naturopathic doctor 0:42 practicing in sunny 0:42 practicing in sunny Arizona. I 0:43 Arizona. I 0:43 Arizona. I work with women every week who are 0:44 work with women every week who are 0:44 work with women every week who are making decisions 0:46 making decisions 0:46 making decisions about HRT. And the conversation 0:47 about HRT. And the conversation 0:47 about HRT. And the conversation about breast cancer 0:48 about breast cancer 0:48 about breast cancer almost always 0:49 almost always 0:49 almost always starts in the same 0:50 starts in the same 0:50 starts in the same place. Fear 0:52 place. Fear 0:52 place. Fear that has formed 0:53 that has formed 0:53 that has formed due to incomplete 0:54 due to incomplete 0:54 due to incomplete information, usually 0:56 information, usually 0:56 information, usually since 2002. Today I 0:59 since 2002. Today I 0:59 since 2002. Today I want to give you the 1:00 want to give you the 1:00 want to give you the factual evidence, the 1:01 factual evidence, the 1:01 factual evidence, the absolute 1:03 absolute 1:03 absolute risk figures, the difference between estrogen- 1:04 risk figures, the difference between estrogen- 1:04 risk figures, the difference between estrogen- only HRT 1:05 only HRT 1:05 only HRT and combined HRT, 1:07 and combined HRT, 1:07 and combined HRT, what the 1:08 what the 1:08 what the 1:10 WHI study actually measured and what 1:10 WHI study actually measured and what its real 1:11 its real 1:11 its real limitations were, and what 1:13 limitations were, and what 1:13 limitations were, and what changed in 2025 1:14 changed in 2025 1:14 changed in 2025 when the FDA updated its 1:16 when the FDA updated its 1:16 when the FDA updated its guidelines. This is not 1:18 guidelines. This is not 1:18 guidelines. This is not necessarily a video in 1:20 necessarily a video in 1:20 necessarily a video in support of HRT. This is 1:21 support of HRT. This is 1:21 support of HRT. This is a video with real 1:22 a video with real 1:22 a video with real photography. Here's what
What the WHI Trial Actually Measured 1:24 photography. Here's what 1:24 photography. Here's what really happened in 1:25 really happened in 1:25 really happened in 2002. The 1:27 2002. The 1:29 Women's Health Initiative study was 1:29 Women's Health Initiative study was terminated early 1:30 terminated early . The reason was the 1:31 . The reason was the 1:31 . The reason was the increased risk of 1:32 increased risk of 1:32 increased risk of breast cancer 1:33 breast cancer 1:33 breast cancer in women taking 1:34 in women taking 1:34 in women taking combination 1:35 combination 1:35 combination hormone therapy. 1:36 hormone therapy. 1:39 The headlines were 1:39 The headlines were immediate and 1:39 immediate and 1:39 immediate and alarming. Within a 1:42 alarming. Within a 1:42 alarming. Within a year, the prescription of HRT 1:43 year, the prescription of HRT 1:43 year, the prescription of HRT was halved. 1:45 was halved. 1:45 was halved. The fear never 1:47 The fear never 1:47 The fear never completely disappeared. And here's the 1:48 completely disappeared. And here's the 1:48 completely disappeared. And here's the thing, the research was 1:50 thing, the research was 1:50 thing, the research was real, and the 1:50 real, and the 1:50 real, and the results were 1:51 results were 1:51 results were real. This is not to 1:53 real. This is not to 1:55 ignore 1:55 ignore concerns, but the 1:56 concerns, but the 1:56 concerns, but the study also 1:57 study also 1:57 study also had significant 1:57 had significant 1:57 had significant design limitations 1:59 design limitations 1:59 design limitations that changed how the 2:00 that changed how the 2:03 results should be interpreted. And these 2:03 results should be interpreted. And these restrictions almost 2:03 restrictions almost 2:04 restrictions almost never made 2:05 never made 2:05 never made headlines. 2:06 headlines. 2:06 headlines. Most importantly, the 2:08 Most importantly, the average age of women in the 2:09 average age of women in the 2:09 average age of women in the WHI study 2:11 WHI study 2:11 WHI study was 63 years. The 2:12 was 63 years. The 2:12 was 63 years. The typical woman who 2:14 typical woman who 2:14 typical woman who starts HRT to 2:15 starts HRT to 2:15 starts HRT to treat menopause 2:16 treat menopause 2:16 treat menopause is between 50 and 52 2:18 is between 50 and 52 2:18 is between 50 and 52 years old. So, 2:18 years old. So, 2:19 years old. So, the study 2:19 the study 2:19 the study answered a very 2:20 answered a very 2:20 answered a very specific question. What 2:22 specific question. What 2:22 specific question. What happens when you 2:23 happens when you 2:23 happens when you prescribe HRT to 2:24 prescribe HRT to 2:24 prescribe HRT to women who 2:25 women who 2:25 women who have been 2:26 have been 2:26 have been postmenopausal 2:27 postmenopausal 2:27 postmenopausal for 10 years or 2:28 for 10 years or 2:28 for 10 years or more? Is 2:29 more? Is 2:29 more? Is HRT safe if 2:30 HRT safe if 2:30 HRT safe if started during 2:32 started during 2:32 started during menopause? These are two 2:34 menopause? These are two 2:34 menopause? These are two different questions, and 2:35 different questions, and 2:35 different questions, and the answers to them are two 2:36 the answers to them are two 2:36 the answers to them are two different things. There is a 2:38 different things. There is a 2:38 different things. There is a second limitation that 2:39 second limitation that 2:39 second limitation that almost no one 2:40 almost no one 2:40 almost no one talks about. 2:41 talks about. 2:42 talks about. The progestogen 2:42 The progestogen 2:42 The progestogen 2:44 used in the 2:44 used in the pooled arm of 2:45 pooled arm of 2:45 pooled arm of this study 2:46 this study 2:46 this study was 2:46 was 2:46 was madroxyprogesterone acetate 2:48 madroxyprogesterone acetate , a synthetic 2:48 , a synthetic 2:48 , a synthetic progestin, not 2:49 progestin, not 2:49 progestin, not progesterone. The 2:52 progesterone. The 2:52 progesterone. The breast cancer link 2:53 breast cancer link 2:53 breast cancer link in this study 2:54 in this study 2:54 in this study may be 2:55 may be 2:55 may be specific to this 2:56 specific to this 2:56 specific to this compound and not to 2:57 compound and not to 2:57 compound and not to hormone therapy 2:58 hormone therapy 2:58 hormone therapy in general. The study 3:00 in general. The study 3:00 in general. The study answered a different 3:01 answered a different 3:01 answered a different question than 3:02 question than 3:02 question than most people think. And 3:03 most people think. And 3:03 most people think. And most women have 3:04 most women have 3:04 most women have never heard that 3:05 never heard that 3:05 never heard that part. Here's what the
The Absolute Risk Numbers Explained 3:06 part. Here's what the 3:06 part. Here's what the actual 3:08 actual 3:08 actual 3:09 absolute risk figures look like. 3:09 absolute risk figures look like. The ones that almost never 3:11 The ones that almost never 3:11 The ones that almost never make the 3:12 make the 3:12 make the headlines. 3:12 headlines. 3:12 headlines. Risk communication 3:14 Risk communication 3:14 Risk communication in medicine has a 3:15 in medicine has a 3:15 in medicine has a problem. 3:16 problem. 3:16 problem. Relative risk measures 3:17 Relative risk measures 3:17 Relative risk measures are used 3:18 are used 3:18 are used almost everywhere, and they 3:19 almost everywhere, and they 3:19 almost everywhere, and they sound too big. 3:20 sound too big. 3:20 sound too big. 3:22 Absolute risk indicators are those that tell 3:23 are those that tell 3:23 are those that tell you what is really 3:24 you what is really 3:24 you what is really important for your 3:25 important for your 3:25 important for your individual 3:26 individual 3:26 individual life. And they 3:27 life. And they 3:27 life. And they look completely 3:28 look completely 3:28 look completely different. Let me 3:29 different. Let me 3:29 different. Let me show you what 3:30 show you what 3:30 show you what I mean. For 3:31 I mean. For 3:31 I mean. For combined 3:32 combined 3:32 combined estrogen plus 3:33 estrogen plus 3:33 estrogen plus progestin HRT, the 3:34 progestin HRT, the 3:34 progestin HRT, the absolute increase in 3:35 absolute increase in 3:35 absolute increase in risk is 3:36 risk is 3:36 risk is approximately two 3:37 approximately two 3:37 approximately two additional cases of 3:38 additional cases of 3:38 additional cases of breast cancer 3:39 breast cancer 3:40 breast cancer per 1000 women over 5 3:41 per 1000 women over 5 3:41 per 1000 women over 5 years of use. 6 3:43 years of use. 6 3:43 years of use. 6 per 1000 over 10 3:45 per 1000 over 10 3:45 per 1000 over 10 years. This is an actual 3:48 years. This is an actual 3:48 years. This is an actual number. Not a percentage, not a 3:50 number. Not a percentage, not a 3:50 number. Not a percentage, not a relative increase, 3:51 relative increase, 3:51 relative increase, but an actual number. Here's 3:53 but an actual number. Here's 3:53 but an actual number. Here's something that puts it into 3:54 something that puts it into 3:54 something that puts it into perspective. 3:55 perspective. 3:55 perspective. Regular 3:56 Regular 3:56 Regular alcohol consumption, one to two 3:57 alcohol consumption, one to two 3:57 alcohol consumption, one to two drinks per day, 3:58 drinks per day, 3:58 drinks per day, increases the 3:59 increases the 3:59 increases the risk of breast cancer by a similar level 4:00 risk of breast cancer by a similar level 4:00 risk of breast cancer by a similar level . A BMI 4:02 . A BMI 4:02 . A BMI over 30 adds even 4:04 over 30 adds even 4:04 over 30 adds even more. These risks 4:05 more. These risks 4:05 more. These risks are rarely discussed 4:07 are rarely discussed 4:07 are rarely discussed with the same intensity. But 4:08 with the same intensity. But 4:08 with the same intensity. But here's the part of this 4:09 here's the part of this 4:09 here's the part of this story that is 4:10 story that is 4:10 story that is almost never 4:11 almost never 4:11 almost never told. Women in the 4:14 told. Women in the 4:14 told. Women in the WHI trial who 4:15 WHI trial who 4:15 WHI trial who took 4:16 took 4:16 took estrogen alone, that is, women 4:17 estrogen alone, that is, women 4:17 estrogen alone, that is, women who had their 4:18 who had their 4:18 who had their estrogen removed and did not 4:19 estrogen removed and did not 4:19 estrogen removed and did not need 4:20 need 4:20 need progestin, were 4:21 progestin, were 4:21 progestin, were about 20% less 4:22 about 20% less 4:23 about 20% less likely 4:23 likely 4:23 likely to be diagnosed with 4:25 to be diagnosed with 4:25 to be diagnosed with breast cancer than 4:26 breast cancer than 4:26 breast cancer than women who took a 4:27 women who took a 4:27 women who took a placebo. Same 4:29 placebo. Same 4:29 placebo. Same study, two 4:30 study, two 4:30 study, two groups and opposite 4:31 groups and opposite 4:31 groups and opposite signals. This 4:32 signals. This 4:32 signals. This complexity was completely 4:33 complexity was completely 4:33 complexity was completely lost when 4:34 lost when 4:35 lost when the headlines appeared. 4:36 the headlines appeared. 4:36 the headlines appeared. And that's why 4:37 And that's why 4:37 And that's why percentage 4:38 percentage 4:38 percentage wording is important. When you 4:40 wording is important. When you 4:40 wording is important. When you hear about a 23% 4:41 hear about a 23% increased risk of 4:42 increased risk of 4:42 increased risk of breast cancer 4:43 breast cancer 4:44 breast cancer from HRT, it sounds 4:45 from HRT, it sounds 4:45 from HRT, it sounds alarming. But this 23% 4:46 alarming. But this 23% refers to the basic 4:48 refers to the basic 4:48 refers to the basic level, which is already very 4:50 level, which is already very 4:50 level, which is already very low. The absolute 4:52 low. The absolute 4:52 low. The absolute number that this 4:53 number that this 4:53 number that this percentage gives is 4:54 percentage gives is 4:54 percentage gives is two additional 4:55 two additional 4:55 two additional cases per 1,000 women 4:57 cases per 1,000 women 4:57 cases per 1,000 women over 5 years. That's what 4:58 over 5 years. That's what 5:00 the calculations actually say. 5:00 the calculations actually say. In my practice, I 5:02 In my practice, I 5:02 In my practice, I explain this 5:03 explain this 5:03 explain this to patients every week. And almost 5:05 to patients every week. And almost 5:05 to patients every week. And almost every time a woman 5:07 every time a woman 5:07 every time a woman hears an actual number, 5:08 hears an actual number, 5:08 hears an actual number, rather than a percentage, a number, 5:09 rather than a percentage, a number, 5:09 rather than a percentage, a number, her entire body visibly 5:10 her entire body visibly 5:11 her entire body visibly relaxes. She 5:13 relaxes. She 5:13 relaxes. She felt a fear that 5:15 felt a fear that 5:15 felt a fear that was much greater 5:16 was much greater 5:16 was much greater than the actual risk. 5:17 than the actual risk.
What Changed in 2025 With FDA Guidance 5:18 than the actual risk. The evidence 5:19 The evidence 5:19 The evidence has changed significantly since 5:21 has changed significantly since 5:21 has changed significantly since 2002. Here's what 5:23 2002. Here's what 5:23 2002. Here's what has changed in the 5:24 has changed in the 5:24 has changed in the last 2 years. In 5:26 last 2 years. In 5:26 last 2 years. In 2025, two 5:27 2025, two 5:27 2025, two important things happened that 5:29 important things happened that 5:29 important things happened that most women haven't 5:30 most women haven't 5:30 most women haven't heard about. The first was 5:31 heard about. The first was 5:31 heard about. The first was regulatory. In 5:33 regulatory. In 5:33 regulatory. In November 2025, the FDA 5:34 November 2025, the FDA 5:34 November 2025, the FDA removed the 5:35 removed the 5:38 black box warning from 5:38 black box warning from many 5:39 many 5:39 many HRT products. If you've never 5:41 HRT products. If you've never 5:41 HRT products. If you've never heard of a 5:42 heard of a 5:44 black box warning, it's 5:44 black box warning, it's the most serious 5:45 the most serious 5:45 the most serious warning the FDA 5:46 warning the FDA 5:46 warning the FDA places on medications. 5:47 places on medications. 5:48 places on medications. Its removal is no 5:49 Its removal is no 5:49 Its removal is no small matter. This is a signal 5:51 small matter. This is a signal 5:51 small matter. This is a signal that a nuanced 5:52 that a nuanced 5:52 that a nuanced picture of risk and 5:53 picture of risk and 5:53 picture of risk and benefit is no longer 5:54 benefit is no longer 5:54 benefit is no longer served by a 5:55 served by a 5:55 served by a blanket 5:55 blanket 5:55 blanket warning of 5:56 warning of 5:56 warning of high severity. 5:57 high severity. 5:58 high severity. The evidence has changed. 5:59 The evidence has changed. 5:59 The evidence has changed. Federal 6:00 Federal 6:00 Federal guidelines 6:00 guidelines 6:00 guidelines changed with 6:01 changed with 6:01 changed with them. The second shift 6:02 them. The second shift 6:02 them. The second shift was clinical. In 6:04 was clinical. In 6:04 was clinical. In September 2025, a panel of 6:05 September 2025, a panel of 6:05 September 2025, a panel of experts 6:06 experts 6:06 experts published 6:07 published 6:07 published updated 6:08 updated 6:08 updated recommendations in the 6:09 recommendations in the 6:09 recommendations in the journal Menopause. 6:10 journal Menopause. 6:13 They recommended that 6:13 They recommended that some women with a 6:14 some women with a 6:14 some women with a personal history of 6:15 personal history of 6:15 personal history of breast cancer 6:16 breast cancer 6:16 breast cancer consider systemic 6:17 consider systemic 6:18 consider systemic HRT to improve 6:19 HRT to improve 6:19 HRT to improve quality of life after an 6:20 quality of life after an 6:20 quality of life after an individual 6:21 individual 6:21 individual discussion with their 6:22 discussion with their 6:22 discussion with their doctor. Let 6:24 doctor. Let 6:24 doctor. Let me explain clearly 6:25 me explain clearly 6:25 me explain clearly what this means. This is not a 6:26 what this means. This is not a 6:26 what this means. This is not a general 6:27 general 6:27 general recommendation. This is not a 6:29 recommendation. This is not a 6:29 recommendation. This is not a resolution for everyone, but 6:30 resolution for everyone, but 6:30 resolution for everyone, but it reflects 6:32 it reflects 6:32 it reflects how significantly 6:33 how significantly 6:33 how significantly clinical opinion has changed 6:34 clinical opinion has changed 6:34 clinical opinion has changed since 2002. There is 6:37 since 2002. There is 6:37 since 2002. There is another aspect that is 6:38 another aspect that is 6:38 another aspect that is now widely 6:39 now widely 6:39 now widely accepted in the 6:40 accepted in the 6:40 accepted in the industry. It 6:41 industry. It 6:41 industry. It is called the 6:42 is called the 6:42 is called the time hypothesis. HRT 6:44 time hypothesis. HRT 6:44 time hypothesis. HRT started within 10 6:46 started within 10 6:46 started within 10 years of 6:47 years of 6:47 years of menopause, what 6:48 menopause, what 6:48 menopause, what researchers call the 6:50 researchers call the 6:50 researchers call the critical window, has a 6:51 critical window, has a 6:51 critical window, has a significantly more favorable 6:53 significantly more favorable 6:53 significantly more favorable safety profile than 6:54 safety profile than 6:54 safety profile than HRT started 6:55 HRT started 6:55 HRT started 10 or more years 6:56 10 or more years 6:56 10 or more years after menopause. The WHI 6:58 after menopause. The WHI 6:58 after menopause. The WHI studied late 7:00 studied late 7:00 studied late initiators. 7:01 initiators. 7:01 initiators. Most menopausal women 7:02 Most menopausal women 7:02 Most menopausal women are early 7:04 are early 7:04 are early starters. This 7:05 starters. This 7:05 starters. This distinction significantly 7:06 distinction significantly 7:06 distinction significantly changes the 7:07 changes the 7:07 changes the risk equation. This does not mean 7:09 risk equation. This does not mean 7:09 risk equation. This does not mean that HRT is risk-free. 7:11 that HRT is risk-free. 7:13 This means 7:13 This means the conversation needs to be 7:14 the conversation needs to be 7:14 the conversation needs to be more specific 7:15 more specific 7:15 more specific about you, your type of 7:16 about you, your type of 7:16 about you, your type of HRT, your timing, and 7:18 HRT, your timing, and 7:18 HRT, your timing, and your individual 7:19 your individual 7:19 your individual risk factors. If 7:22 risk factors. If 7:22 risk factors. If you found this 7:22 you found this 7:22 you found this helpful, if you have 7:24 helpful, if you have 7:24 helpful, if you have made decisions 7:25 made decisions 7:25 made decisions about HRT based on 7:26 about HRT based on 7:26 about HRT based on incomplete information, please 7:27 incomplete information, please 7:27 incomplete information, please subscribe. I 7:28 subscribe. I 7:28 subscribe. I publish 7:29 publish 7:29 publish honest, 7:30 honest, 7:31 honest, evidence-based content about 7:32 evidence-based content about 7:32 evidence-based content about hormonal health every week. 7:33 hormonal health every week. 7:33 hormonal health every week. Stay with me 7:34 Stay with me 7:34 Stay with me to receive 7:35 to receive 7:35 to receive personalized 7:36 personalized
The Individual Risk Framework 7:38 risk framework information. The question 7:40 most women ask is: does 7:40 most women ask is: does HRT cause 7:41 HRT cause 7:41 HRT cause breast cancer? This is 7:43 breast cancer? This is 7:43 breast cancer? This is n't a wrong 7:44 n't a wrong 7:44 n't a wrong question, but it's 7:45 question, but it's 7:45 question, but it's also not the 7:45 also not the 7:45 also not the most useful one. The better 7:47 most useful one. The better 7:47 most useful one. The better question, given 7:48 question, given 7:48 question, given my specific 7:49 my specific 7:49 my specific situation, is what is my 7:50 situation, is what is my 7:50 situation, is what is my individual 7:51 individual 7:51 individual risk/ 7:53 risk/ benefit calculation? Because 7:55 benefit calculation? Because 7:55 benefit calculation? Because the answer is different for 7:56 the answer is different for 7:56 the answer is different for every woman. 7:57 every woman. 7:59 Let me 7:59 Let me explain what 8:00 explain what 8:00 explain what actually changes 8:01 actually changes 8:01 actually changes the equation. The first 8:02 the equation. The first 8:02 the equation. The first variable is the type. 8:03 variable is the type. 8:04 variable is the type. Estrogen alone 8:05 Estrogen alone 8:05 Estrogen alone versus combined 8:06 versus combined 8:06 versus combined HRT do not have the 8:07 HRT do not have the 8:07 HRT do not have the same 8:08 same 8:08 same risk profile. Oral 8:10 risk profile. Oral 8:10 risk profile. Oral combined HRT using 8:11 combined HRT using 8:11 combined HRT using 8:13 synthetic 8:13 synthetic progestins has a 8:14 progestins has a 8:14 progestins has a slight increase in the 8:15 slight increase in the 8:15 slight increase in the risk we 8:16 risk we 8:16 risk we discussed earlier. 8:17 discussed earlier. 8:18 discussed earlier. Transdermal 8:18 Transdermal 8:18 Transdermal estradiol 8:19 estradiol 8:19 estradiol combined with 8:20 combined with 8:20 combined with oral 8:21 oral 8:21 oral micronized 8:21 micronized 8:21 micronized progesterone ( 8:22 progesterone ( bioidentical 8:23 bioidentical 8:23 bioidentical progesterone) 8:24 progesterone) 8:24 progesterone) appears to have a different 8:25 appears to have a different 8:25 appears to have a different profile. They are not 8:27 profile. They are not 8:27 profile. They are not interchangeable. Type 8:29 interchangeable. Type 8:29 interchangeable. Type matters. The second 8:30 matters. The second 8:30 matters. The second variable is duration. 8:31 variable is duration. 8:32 variable is duration. Short-term 8:33 Short-term 8:33 Short-term use of up to five 8:34 use of up to five 8:34 use of up to five years has a different 8:35 years has a different 8:35 years has a different risk profile than 8:36 risk profile than 8:36 risk profile than long-term use 8:38 long-term use . This is a conversation that 8:39 . This is a conversation that 8:39 . This is a conversation that should be discussed with 8:40 should be discussed with 8:40 should be discussed with your doctor before you 8:41 your doctor before you 8:42 your doctor before you start, not after 8:43 start, not after . The third variable is time 8:45 . The third variable is time . When did your 8:47 . When did your 8:47 . When did your menopause begin? If you 8:48 menopause begin? If you 8:48 menopause begin? If you are within 8:49 are within 8:49 are within 10 years of the onset of 8:51 10 years of the onset of 8:51 10 years of the onset of menopause, you 8:51 menopause, you 8:51 menopause, you are in a 8:52 are in a 8:52 are in a critical window. This is 8:54 critical window. This is 8:54 critical window. This is the scenario with the 8:55 the scenario with the 8:55 the scenario with the most favorable 8:56 most favorable 8:56 most favorable safety data. The WHI 8:57 safety data. The WHI 8:57 safety data. The WHI studied women who 8:58 studied women who 8:58 studied women who were well outside 9:00 were well outside 9:00 were well outside this window. 9:01 this window. 9:01 this window. Most women who 9:02 Most women who 9:02 Most women who start HRT 9:03 start HRT 9:03 start HRT today 9:03 today 9:03 today are 9:04 are 9:04 are within it. The 9:05 within it. The 9:05 within it. The fourth variable is 9:06 fourth variable is 9:06 fourth variable is you. Family history of 9:07 you. Family history of 9:07 you. Family history of breast cancer, 9:09 breast cancer, 9:09 breast cancer, Braque status, 9:10 Braque status, 9:10 Braque status, previous biopsies 9:11 previous biopsies 9:11 previous biopsies showing atypical 9:12 showing atypical 9:12 showing atypical cells, dense 9:13 cells, dense 9:13 cells, dense breast tissue 9:14 breast tissue 9:14 breast tissue , 9:15 , 9:15 , alcohol use, BMI over 30. 9:17 alcohol use, BMI over 30. 9:17 alcohol use, BMI over 30. All of these raise your 9:18 All of these raise your 9:18 All of these raise your baseline risk before 9:19 baseline risk before 9:19 baseline risk before HRT even 9:20 HRT even 9:20 HRT even comes into the conversation. And 9:22 comes into the conversation. And 9:22 comes into the conversation. And that should be part of the 9:24 that should be part of the 9:24 that should be part of the conversation. That's why I 9:26 conversation. That's why I 9:26 conversation. That's why I tell my patients 9:27 tell my patients 9:27 tell my patients that the goal is not to 9:28 that the goal is not to 9:28 that the goal is not to find a "yes 9:30 find a "yes " or a "no." The goal is to 9:31 " or a "no." The goal is to 9:33 find your number, 9:33 find your number, your individual 9:34 your individual 9:34 your individual risk, weighed against 9:35 risk, weighed against 9:35 risk, weighed against your 9:35 your 9:35 your individual 9:36 individual 9:36 individual symptoms, 9:37 symptoms, 9:37 symptoms, your quality of life, and your 9:39 your quality of life, and your 9:39 your quality of life, and your specific 9:40 specific 9:40 specific health history. This is the 9:41 health history. This is the 9:41 health history. This is the conversation that is worth 9:42 conversation that is worth 9:42 conversation that is worth having. And it requires a 9:44 having. And it requires a 9:44 having. And it requires a doctor who understands 9:45 doctor who understands 9:45 doctor who understands both sides. Here's
What to Bring to Your Doctor Conversation 9:47 both sides. Here's 9:47 both sides. Here's the gist of what to go with. 9:49 the gist of what to go with. 9:51 The purpose of this video 9:51 The purpose of this video was never 9:52 was never 9:52 was never to tell you to take 9:53 to tell you to take 9:54 to tell you to take HRT or avoid it. 9:55 HRT or avoid it. 9:55 HRT or avoid it. It was about 9:56 It was about 9:56 It was about making sure that 9:57 making sure that 9:57 making sure that whatever decision you 9:58 whatever decision you 9:58 whatever decision you make, you 9:58 make, you 9:58 make, you make it based on 9:59 make it based on 9:59 make it based on accurate 10:00 accurate 10:00 accurate information. So, here's what you should 10:01 information. So, here's what you should 10:01 information. So, here's what you should bring with you 10:02 bring with you 10:03 bring with you to your next conversation with 10:04 to your next conversation with 10:04 to your next conversation with your doctor. Know the 10:05 your doctor. Know the 10:05 your doctor. Know the absolute 10:06 absolute 10:06 absolute risk number. Two extra 10:08 risk number. Two extra 10:08 risk number. Two extra cases of 10:09 cases of 10:09 cases of breast cancer per 1000 10:11 breast cancer per 1000 10:11 breast cancer per 1000 women during 5 10:12 women during 5 10:12 women during 5 years of combined 10:13 years of combined 10:13 years of combined HRT. Not a percentage, but 10:16 HRT. Not a percentage, but 10:16 HRT. Not a percentage, but a number. If your doctor 10:18 a number. If your doctor 10:18 a number. If your doctor tells you a 10:18 tells you a 10:18 tells you a relative 10:20 relative 10:20 relative risk percentage, you now 10:20 risk percentage, you now 10:21 risk percentage, you now know what to 10:22 know what to 10:22 know what to ask: "What does that 10:23 ask: "What does that 10:23 ask: "What does that look like in 10:23 look like in 10:23 look like in absolute 10:24 absolute 10:24 absolute terms?" Know 10:25 terms?" Know 10:25 terms?" Know the results obtained 10:26 the results obtained 10:26 the results obtained with 10:27 with 10:28 with estrogen alone. If you have had 10:29 estrogen alone. If you have had 10:29 estrogen alone. If you have had a hysterectomy, 10:30 a hysterectomy, 10:30 a hysterectomy, estrogen-only HRT 10:32 estrogen-only HRT 10:32 estrogen-only HRT showed a reduced 10:33 showed a reduced 10:33 showed a reduced risk of breast cancer 10:34 risk of breast cancer 10:34 risk of breast cancer in the WHI. Your 10:36 in the WHI. Your 10:36 in the WHI. Your risk equation is 10:37 risk equation is 10:37 risk equation is fundamentally 10:37 fundamentally 10:37 fundamentally different from 10:38 different from 10:38 different from that of a woman 10:39 that of a woman 10:39 that of a woman taking combined 10:41 taking combined 10:41 taking combined HRT. Make sure 10:42 HRT. Make sure 10:42 HRT. Make sure this distinction is 10:43 this distinction is 10:43 this distinction is part of your 10:44 part of your 10:44 part of your conversation. Ask 10:46 conversation. Ask 10:46 conversation. Ask about the type of medication. 10:47 about the type of medication. 10:47 about the type of medication. Oral 10:47 Oral 10:47 Oral combined HRT with 10:48 combined HRT with 10:48 combined HRT with synthetic 10:49 synthetic 10:49 synthetic progestin and 10:50 progestin and 10:50 progestin and transdermal 10:51 transdermal 10:51 transdermal estradiol with 10:52 estradiol with 10:52 estradiol with bioidentical 10:53 bioidentical 10:53 bioidentical progesterone do not 10:54 progesterone do not 10:54 progesterone do not have the same 10:55 have the same 10:55 have the same risk profile. 10:55 risk profile. 10:56 risk profile. Ask which one is 10:57 Ask which one is 10:57 Ask which one is recommended to you and 10:58 recommended to you and 10:58 recommended to you and why. Ask about 11:00 why. Ask about 11:00 why. Ask about your time. When 11:01 your time. When 11:01 your time. When did your 11:02 did your 11:02 did your menopause begin? Are 11:02 menopause begin? Are 11:03 menopause begin? Are you 11:03 you 11:03 you within this 10-year 11:05 within this 10-year 11:05 within this 10-year window, 11:05 window, 11:05 window, called the 11:06 called the 11:06 called the critical window? This very 11:07 critical window? This very 11:07 critical window? This very question could 11:08 question could 11:08 question could rethink the entire 11:09 rethink the entire 11:09 rethink the entire conversation about risk. And 11:11 conversation about risk. And 11:11 conversation about risk. And finally, honestly 11:12 finally, honestly 11:12 finally, honestly compare your 11:13 compare your 11:13 compare your risks. 11:14 risks. 11:15 risks. Alcohol consumption, increased 11:16 Alcohol consumption, increased 11:16 Alcohol consumption, increased BMI, and a sedentary 11:17 BMI, and a sedentary 11:17 BMI, and a sedentary lifestyle all 11:18 lifestyle all 11:18 lifestyle all carry a risk of 11:19 carry a risk of 11:19 carry a risk of breast cancer. They 11:21 breast cancer. They 11:21 breast cancer. They rarely cause the 11:22 rarely cause the 11:22 rarely cause the same fear as 11:23 same fear as 11:23 same fear as HRT. Make sure 11:25 HRT. Make sure 11:25 HRT. Make sure you are weighing the 11:25 you are weighing the 11:25 you are weighing the right things 11:27 right things 11:27 right things against each other. The 11:27 against each other. The 11:27 against each other. The 11:30 FDA's 2025 update of recommendations 11:30 FDA's 2025 update of recommendations is a signal. 11:32 is a signal. 11:32 is a signal. The evolution of the 11:33 The evolution of the 11:33 The evolution of the clinical community's position 11:34 clinical community's position is a signal. The conversation 11:36 is a signal. The conversation 11:36 is a signal. The conversation definitely changed the subject. 11:38 definitely changed the subject. 11:38 definitely changed the subject. Make sure 11:39 Make sure 11:39 Make sure yours is too. That's what we 11:41 yours is too. That's what we 11:41 yours is too. That's what we looked at today. The 11:42 looked at today. The 11:44 breast cancer scare 11:44 breast cancer scare surrounding HRT was 11:45 surrounding HRT was 11:45 surrounding HRT was based on 11:46 based on 11:46 based on real 11:46 real 11:46 real studies with 11:47 studies with 11:47 studies with real 11:48 real 11:48 real limitations that were 11:49 limitations that were 11:49 limitations that were almost never 11:50 almost never 11:50 almost never explained. The 11:51 explained. The 11:51 explained. The WHI study 11:52 WHI study 11:52 WHI study studied women with an 11:53 studied women with an 11:53 studied women with an average age of 63 years 11:55 average age of 63 years . Most women who 11:57 . Most women who 11:57 . Most women who start HRT are between the 11:59 start HRT are between the 11:59 start HRT are between the ages of 50 and 52. This is a 12:00 ages of 50 and 52. This is a 12:00 ages of 50 and 52. This is a different population that 12:02 different population that 12:02 different population that answers a different 12:03 answers a different 12:03 answers a different question. The absolute 12:05 question. The absolute 12:05 question. The absolute risk of combined 12:06 risk of combined 12:06 risk of combined HRT is two 12:07 HRT is two 12:07 HRT is two additional cases per 12:09 additional cases per 12:09 additional cases per 10,000 women over 5 12:10 10,000 women over 5 12:10 10,000 women over 5 years. Not zero, but 12:12 years. Not zero, but 12:12 years. Not zero, but not what the 12:13 not what the 12:13 not what the headlines implied either. HRT 12:15 headlines implied either. HRT 12:15 headlines implied either. HRT with estrogen 12:16 with estrogen 12:16 with estrogen showed a 12:16 showed a 12:16 showed a productive signal 12:17 productive signal 12:17 productive signal in the same study. 12:19 in the same study. 12:19 in the same study. The FDA updated its 12:20 The FDA updated its 12:21 The FDA updated its guidelines in 12:22 guidelines in 12:22 guidelines in November 2025. The 12:24 November 2025. The 12:26 clinical community 12:26 clinical community has changed, and the type of HRT, 12:27 has changed, and the type of HRT, 12:27 has changed, and the type of HRT, timing of initiation, and your 12:29 timing of initiation, and your 12:29 timing of initiation, and your individual 12:30 individual 12:30 individual risk factors 12:31 risk factors 12:31 risk factors have changed the equation. 12:32 have changed the equation. 12:34 Bring actual 12:34 Bring actual numbers to your 12:35 numbers to your 12:35 numbers to your next conversation. You 12:37 next conversation. You 12:37 next conversation. You deserve a 12:38 deserve a 12:38 deserve a decision based on the 12:39 decision based on the 12:39 decision based on the real picture, 12:40 real picture, 12:40 real picture, not a headline from 12:42 not a headline from 12:42 not a headline from 2002. If this has changed 12:44 2002. If this has changed 12:44 2002. If this has changed your perception of HRT, the 12:45 your perception of HRT, the 12:45 your perception of HRT, the natural next 12:46 natural next 12:47 natural next video to watch 12:48 video to watch 12:48 video to watch would be my analysis of 12:49 would be my analysis of 12:49 would be my analysis of bioidentical and 12:50 bioidentical and 12:50 bioidentical and synthetic HRT. It 12:52 synthetic HRT. It 12:54 explains in detail why the type of 12:54 explains in detail why the type of progesterone 12:55 progesterone 12:55 progesterone seems to 12:55 seems to 12:55 seems to matter for 12:57 matter for 12:57 matter for breast cancer risk, 12:58 breast cancer risk, 12:58 breast cancer risk, and that's the thread 12:59 and that's the thread 12:59 and that's the thread we 13:00 we 13:00 we started with today. I'll give 13:01 started with today. I'll give 13:01 started with today. I'll give the link here. It is worth 13:03 the link here. It is worth 13:03 the link here. It is worth noting that the fear 13:04 noting that the fear 13:04 noting that the fear was not 13:04 was not 13:04 was not irrational. It was 13:06 irrational. It was 13:06 irrational. It was based on 13:07 based on 13:07 based on incomplete information. 13:08 incomplete information. 13:08 incomplete information. Now you have the complete 13:10 Now you have the complete 13:10 Now you have the complete picture. Leave 13:11 picture. Leave 13:11 picture. Leave a comment and tell 13:12 a comment and tell 13:12 a comment and tell me if the 13:14 me if the 13:14 me if the 2002 WHI study has influenced 13:15 2002 WHI study has influenced 13:15 2002 WHI study has influenced your 13:16 your 13:16 your attitude towards HRT? 13:17 attitude towards HRT? 13:18 attitude towards HRT? I sincerely wonder 13:19 I sincerely wonder 13:19 I sincerely wonder how many women still 13:20 how many women still 13:20 how many women still make decisions 13:21 make decisions 13:21 make decisions based on 13:22 based on 13:22 based on this headline alone. And 13:24 this headline alone. And 13:24 this headline alone. And if you've been looking for honest, 13:25 if you've been looking for honest, 13:25 if you've been looking for honest, grounded 13:26 grounded 13:26 grounded education about 13:27 education about 13:27 education about hormonal health 13:28 hormonal health 13:28 hormonal health without intimidation in 13:29 without intimidation in 13:29 without intimidation in any direction, 13:30 any direction, 13:31 any direction, then this channel is for 13:32 then this channel is for 13:32 then this channel is for you. Subscribe so you 13:34 you. Subscribe so you 13:34 you. Subscribe so you don't miss what's 13:35 don't miss what's 13:35 don't miss what's next.
Comments